Literature DB >> 14608498

Osteogenesis imperfecta in childhood: effects of spondylodesis on functional ability, ambulation and perceived competence.

N Tolboom1, E A Cats, P J M Helders, J E H Pruijs, R H H Engelbert.   

Abstract

We studied the effects of spondylodesis on spinal curvature, functional outcome, level of ambulation and perceived competence in 11 children with osteogenesis imperfecta (OI). Mean age at surgical intervention was 13.1 years (SD 2.5 years) and follow-up amounted to 3.4 years (SD 2.3 years). Spinal curvature was measured according to Cobb. The level of ambulation was scored according to the modified criteria of Bleck. Functional abilities and the amount of parental assistance were scored using the Dutch version of the Pediatric Evaluation of Disability Inventory (PEDI). Perceived competence was measured using the Harter Self-Perception Profile for Children. The amount of fatigue, spinal pain and presence of subjective dyspnea were scored with a visual analog scale. The median progression per year before spondylodesis was 6.1 degrees (interquartile range 2.9 degrees -12.9 degrees ) and after the spondylodesis it was 5.0 degrees (interquartile range 1.6 degrees -11.0 degrees ). No significant progression or regression in the level of ambulation was found. Perceived competence improved slightly. In the total score of the perceived competence, a borderline significant increase was found ( P-value 0.068). We concluded that spinal fusion in children with OI does not materially influence functional ability and level of ambulation. Self-perceived competence seemed to improve after surgery. The amount of pain, fatigue and subjective dyspnea seemed to diminish after spinal surgery. Progression of scoliosis proceeded, as did development of spinal curvature at the junction of the spondylodesis. Therefore, oral or intravenous bisphosphonates before and after spinal surgery should be considered.

Entities:  

Mesh:

Year:  2003        PMID: 14608498      PMCID: PMC3476567          DOI: 10.1007/s00586-003-0574-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  19 in total

1.  Dutch adaptation and content validity of the 'Pediatric Evaluation Of Disability Inventory (PEDI)'.

Authors:  J W H Custers; J E Wassenberg-Severijnen; J Van der Net; A Vermeer; H T Hart; P J M Helders
Journal:  Disabil Rehabil       Date:  2002-03-20       Impact factor: 3.033

2.  Osteogenesis imperfecta in childhood: perceived competence in relation to impairment and disability.

Authors:  R H Engelbert; V A Gulmans; C S Uiterwaal; P J Helders
Journal:  Arch Phys Med Rehabil       Date:  2001-07       Impact factor: 3.966

3.  Discriminative validity of the Dutch Pediatric Evaluation of Disability Inventory.

Authors:  Jan W Custers; Janjaap van der Net; Herbert Hoijtink; Jeltje E Wassenberg-Severijnen; Adri Vermeer; Paul J Helders
Journal:  Arch Phys Med Rehabil       Date:  2002-10       Impact factor: 3.966

4.  Operative treatment of severe scoliosis in osteogenesis imperfecta: results of 20 patients after halo traction and posterior spondylodesis with instrumentation.

Authors:  G J Janus; G Finidori; R H Engelbert; M Pouliquen; J E Pruijs
Journal:  Eur Spine J       Date:  2000-12       Impact factor: 3.134

5.  Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta.

Authors:  R F Widmann; F D Bitan; F J Laplaza; S W Burke; M F DiMaio; R Schneider
Journal:  Spine (Phila Pa 1976)       Date:  1999-08-15       Impact factor: 3.468

6.  Osteogenesis imperfecta in childhood: prognosis for walking.

Authors:  R H Engelbert; C S Uiterwaal; V A Gulmans; H Pruijs; P J Helders
Journal:  J Pediatr       Date:  2000-09       Impact factor: 4.406

Review 7.  The use of bisphosphonates in children with osteogenesis imperfecta.

Authors:  F H Glorieux
Journal:  J Pediatr Endocrinol Metab       Date:  2001       Impact factor: 1.634

8.  Spinal rotation meter: development and comparison of a new device.

Authors:  J E Pruijs; M A Hageman; W Keessen; R Van der Meer; J C Van Wieringen
Journal:  Acta Orthop Belg       Date:  1995       Impact factor: 0.500

9.  Vertebral body shape as a predictor of spinal deformity in osteogenesis imperfecta.

Authors:  S Ishikawa; S J Kumar; H E Takahashi; M Homma
Journal:  J Bone Joint Surg Am       Date:  1996-02       Impact factor: 5.284

10.  The spine in osteogenesis imperfecta.

Authors:  D R Benson; D H Donaldson; E A Millar
Journal:  J Bone Joint Surg Am       Date:  1978-10       Impact factor: 5.284

View more
  4 in total

Review 1.  The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review.

Authors:  Argerie Tsimicalis; Gabrielle Denis-Larocque; Alisha Michalovic; Carolann Lepage; Karl Williams; Tian-Ran Yao; Telma Palomo; Noemi Dahan-Oliel; Sylvie Le May; Frank Rauch
Journal:  Qual Life Res       Date:  2016-02-19       Impact factor: 4.147

2.  Effect of Bisphosphonates on Function and Mobility Among Children With Osteogenesis Imperfecta: A Systematic Review.

Authors:  Christopher S Constantino; Joseph J Krzak; Alissa V Fial; Karen M Kruger; Jacob R Rammer; Katarina Radmanovic; Peter A Smith; Gerald F Harris
Journal:  JBMR Plus       Date:  2019-10-18

Review 3.  Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.

Authors:  Maman Joyce Dogba; Frank Rauch; Erin Douglas; Christophe Bedos
Journal:  Health Qual Life Outcomes       Date:  2014-10-25       Impact factor: 3.186

4.  Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta.

Authors:  Brigitte Mueller; Raoul Engelbert; Frances Baratta-Ziska; Bart Bartels; Nicole Blanc; Evelise Brizola; Paolo Fraschini; Claire Hill; Caroline Marr; Lisa Mills; Kathleen Montpetit; Verity Pacey; Miguel Rodriguez Molina; Marleen Schuuring; Chantal Verhille; Olga de Vries; Eric Hiu Kwong Yeung; Oliver Semler
Journal:  Orphanet J Rare Dis       Date:  2018-09-10       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.